2-[6-(2,4-Dichloro-phenyl)-hexylsulfanylmethyl]-2-hydroxy-succinic acid

ID: ALA120648

Chembl Id: CHEMBL120648

PubChem CID: 10597619

Max Phase: Preclinical

Molecular Formula: C17H22Cl2O5S

Molecular Weight: 409.33

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CC(O)(CSCCCCCCc1ccc(Cl)cc1Cl)C(=O)O

Standard InChI:  InChI=1S/C17H22Cl2O5S/c18-13-7-6-12(14(19)9-13)5-3-1-2-4-8-25-11-17(24,16(22)23)10-15(20)21/h6-7,9,24H,1-5,8,10-11H2,(H,20,21)(H,22,23)

Standard InChI Key:  QGRRMRPIDRCWTG-UHFFFAOYSA-N

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Acly ATP-citrate synthase (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 409.33Molecular Weight (Monoisotopic): 408.0565AlogP: 4.12#Rotatable Bonds: 12
Polar Surface Area: 94.83Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.72CX Basic pKa: CX LogP: 4.65CX LogD: -0.51
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.45Np Likeness Score: -0.17

References

1. Gribble AD, Dolle RE, Shaw A, McNair D, Novelli R, Novelli CE, Slingsby BP, Shah VP, Tew D, Saxty BA, Allen M, Groot PH, Pearce N, Yates J..  (1996)  ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.,  39  (18): [PMID:8784456] [10.1021/jm960167w]
2. Granchi C..  (2018)  ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.,  157  [PMID:30195238] [10.1016/j.ejmech.2018.09.001]

Source